|
1
|
Motie M, Evangelista LS, Horwich TB, et
al: Pro-HEART - a randomized clinical trial to test the
effectiveness of a high protein diet targeting obese individuals
with heart failure: rationale, design and baseline characteristics.
Contemp Clin Trials. 36:371–381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Horwich TB, Fonarow GC, Hamilton MA,
MacLellan WR, Woo MA and Tillisch JH: The relationship between
obesity and mortality in patients with heart failure. J Am Coll
Cardiol. 38:789–795. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davos CH, Doehner W, Rauchhaus M, Cicoira
M, Francis D, Coats AJ, Clark AL and Anker SD: Body mass and
survival in patients with chronic heart failure without cachexia:
the importance of obesity. J Card Fail. 9:29–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lissin LW, Gauri AJ, Froelicher VF,
Ghayoumi A, Myers J and Giacommini J: The prognostic value of body
mass index and standard exercise testing in male veterans with
congestive heart failure. J Card Fail. 8:206–215. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mosterd A, Cost B, Hoes AW, et al: The
prognosis of heart failure in the general population: The Rotterdam
Study. Eur Heart J. 22:1318–1327. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anker SD, Negassa A, Coats AJ, Afzal A,
Poole-Wilson PA, Cohn JN and Yusuj S: Prognostic importance of
weight loss in chronic heart failure and the effect of treatment
with angiotensin-converting-enzyme inhibitors: an observational
study. Lancet. 361:1077–1083. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castell JV, Gómez-Lechión M, David M, et
al: Acute phase response of human hepatocyte: regulation of
acute-phase protein synthesis by interleukin-6. Hepatology.
12:1179–1186. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ridker M, Buring JE, Cook NR and Rifai N:
C-reactive protein, the metabolic syndrome, and risk of incident
cardiovascular events: an 8-year follow-up of 14719 initially
healthy American women. Circulation. 107:391–397. 2003.PubMed/NCBI
|
|
9
|
Koenig W, Sund M, Fröhlich M, Fischer HG,
Löwel H, Döring A, Hutchinson WL and Pepys MB: C-Reactive protein,
a sensitive marker of inflammation, predicts future risk of
coronary heart disease in initially healthy middle-aged men:
results from the MONICA (Monitoring Trends and Determinants in
Cardiovascular Disease) Ausburg Cohort Study, 1984 to 1992.
Circulation. 99:237–242. 1999.
|
|
10
|
Tracy RP, Lemaitre RN, Psaty BM, Ives DG,
Evans RW, Cushman M, Meilahn EN and Kuller LH: Relationship of
C-reactive protein to cardiovascular disease in the elderly:
results from the Cardiovascular Health Study and the Rural Health
Promotion Project. Arterioscler Thromb Vasc Biol. 17:1121–1127.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rutter MK, Meigs JB, Sullivan LM,
D’Agostino RB Sr and Wilson PW: C-reactive protein, the metabolic
syndrome, and prediction of cardiovascular events in the Framingham
Offspring Study. Circulation. 110:380–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Visser M, Bouter LM, McQuillan GM, Wener
MH and Harris TB: Elevated C-reactive protein levels in overweight
and obese adults. JAMA. 282:2131–2135. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brennan AM and Mantzoros CS: Drug insight:
the role of leptin in human physiology and pathophysiology -
emerging clinical applications. Nat Clin Pract Endocrinol Metab.
2:318–327. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Halaas JL, Gajiwala KS, Maffei M, Cohen
SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM:
Weight-reducing effects of the plasma protein encoded by the obese
gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Franks PW, Brage S, Luan J, Ekelund U,
Rahman M, Farooqi IS, Halsall I, O’Rahilly S and Wareham NJ: Leptin
predicts a worsening of the features of the metabolic syndrome
independently of obesity. Obes Res. 13:1476–1484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wallace AM, McMahon AD, Packard CJ, Kelly
A, Shepherd J, Gaw A and Sattar N: Plasma leptin and the risk of
cardiovascular disease in the west of Scotland coronary prevention
study (WOSCOPS). Circulation. 104:3052–3056. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sierra-Johnson J, Romero-Corral A,
Lopez-Jimenez F, Gami AS, Sert Kuniyoshi FH, Wolk R and Somers VK:
Relation of increased leptin concentrations to history of
myocardial infarction and stroke in the US population. Am J
Cardiol. 100:234–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Söderberg S, Ahrén B, Jansson JH, Johnson
O, Hallmans G, Asplund K and Olsson T: Leptin is associated with
increased risk of myocardial infarction. J Intern Med. 246:409–418.
1999.
|
|
19
|
Singh P, Hoffmann M, Wolk R, Shamsuzzaman
AS and Somers VK: Leptin induces C-reactive protein expression in
vascular endothelial cells. Arterioscler Thromb Vasc Biol.
27:e302–e307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiu FH, Chuang CH, Li WC, Weng YM, Fann
WC, Lo HY, Sun C and Wang SH: The association of leptin and
C-reactive protein with the cardiovascular risk factors and
metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol.
11:402012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shamsuzzaman AS, Winnicki M, Wolk R,
Svatikova A, Phillips BG, Davison DE, Berger PB and Somers VK:
Independent association between plasma leptin and C-reactive
protein in healthy humans. Circulation. 109:2181–2185. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Viikari LA, Huupponen RK, Viikari JS,
Marniemi J, Eklund C, Hurme M, Lhetimäki T, Kivimäki M and
Raitakari OT: Relationship between leptin and C-reactive protein in
young Finnish adults. J Clin Endocrinol Metab. 92:4753–4758. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yanagawa T, Taniguchi A, Fukushima M,
Nakai Y, Nagasaka S, Ohgushi M, Matsumotoe K, Kuroea A, Ohyaa M and
Seinoa Y: Leptin, triglycerides, and interleukin 6 are
independently associated with C-reactive protein in Japanese type 2
diabetic patients. Diabetes Res Clin Pract. 75:2–6. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kazumi T, Kawaguchi A, Hirano T and
Yoshino G: C-reactive protein in young, apparently healthy men:
associations with serum leptin, QTc interval, and high-density
lipoprotein-cholesterol. Metabolism. 52:1113–1116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ble A, Windham BG, Bandinelli S, Taub DD,
Volpato S, Bartali B, Tracy RP, Guralnik JM and Ferrucci L:
Relation of plasma leptin to C-reactive protein in older adults
(from the Invecchiare nel Chianti study). Am J Cardiol. 96:991–995.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen K, Li F, Li J, Cai H, Strom S,
Bisello A, Kelley DE, Friedman-Einat M, Skibinski GA, McCrory MA,
Szalai AJ and Zhao AZ: Induction of leptin resistance through
direct interaction of C-reactive protein with leptin. Nat Med.
12:425–432. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Myers MG Jr, Leibel RL, Seeley RJ and
Schwartx MW: Obesity and leptin resistance: distinguishing cause
from effect. Trends Endocrinol Metab. 21:643–651. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hribal ML, Fiorentino TV and Sesti G: Role
of C reactive protein (CRP) in leptin resistance. Curr Pharm Des.
May 14–2013.(Epub ahead of print).
|
|
29
|
Nguyen XM, Lane J, Smith BR and Nguyen NT:
Changes in inflammatory biomarkers across weight classes in a
representative US population: a link between obesity and
inflammation. J Gastrointest Surg. 13:1205–1212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yudkin JS, Stehouwer CD, Emeis JJ and
Coppack SW: C-reactive protein in healthy subjects: associations
with obesity, insulin resistance, and endothelial dysfunction: a
potential role for cytokines originating from adipose tissue?
Arterioscler Thromb Vasc Biol. 19:972–978. 1999. View Article : Google Scholar
|
|
31
|
Kowalska I: Role of adipose tissue in the
development of vascular complications in type 2 diabetes mellitus.
Diabetes Res Clin Pract. 78:S14–S22. 2007. View Article : Google Scholar
|
|
32
|
Karmazyn M and Rajapurohitam V: Leptin as
a cardiac pro-hypertrophic factor and its potential role in the
development of heart failure. Curr Pharm Des. May 14–2013.(Epub
ahead of print).
|
|
33
|
Khera A, McGuire DK, Murphy SA, Stanek HG,
Das SR, Vongpatanasin W, Wians FH Jr, Grundy SM and de Lemos JA:
Race and gender differences in C-reactive protein levels. J Am Coll
Cardiol. 46:464–469. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khera A, Vega GL, Das SR, Ayers C, McGuire
DK, Grundy SM and de Lemos JA: Sex differences in the relationship
between C-reactive protein and body fat. J Clin Endocrinol Metab.
94:3251–3258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pai JK, Pischon T, Ma J, Manson JE,
Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC,
Stampfer MJ and Rimm EB: Inflammatory markers and the risk of
coronary heart disease in men and women. N Engl J Med.
351:2599–2610. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cushman M, Arnold AM, Psaty BM, Manolio
TA, Kuller LH, Burke GL, Polak JF and Tracy RP: C-reactive protein
and the 10-year incidence of coronary heart disease in older men
and women: the cardiovascular health study. Circulation. 112:25–31.
2005.PubMed/NCBI
|
|
37
|
Doran B, Zhu W and Muennig P: Gender
differences in cardiovascular mortality by C-reactive protein level
in the United States: evidence from the National Health and
Nutrition Examination Survey III. Am Heart J. 166:45–51. 2013.
View Article : Google Scholar
|
